地中海饮食:对抗阿尔茨海默病的强有力的防御 - - 一个全面的审查
1Department of Nutrition and Dietetics, Sarab Branch, Islamic Azad University, Sarab, Iran.
Clinical nutrition ESPEN
|September 30, 2024
概括
地中海饮食可能有助于预防认知能力下降和阿尔茨海默病 (AD). 然而,需要更多的研究,包括随机对照试验,以确认其益处和预防作用.
科学领域:
- 神经科学是一个神经科学.
- 营养科学 营养科学
- 流行病学 流行病学
背景情况:
- 生活方式因素,特别是饮食,越来越多地研究它们在认知衰退和阿尔茨海默病 (AD) 风险中的作用.
- 地中海饮食是一种潜在的饮食干预,通过观察性研究表明,它可以提供对认知障碍的保护.
- 对地中海饮食的高度坚持与认知障碍的风险降低有关,而较低的坚持与阿尔茨海默病的风险增加有关.
研究的目的:
- 探索地中海饮食对认知衰退和阿尔茨海默病 (AD) 风险的潜在影响.
- 审查当前证据,将地中海饮食的遵守与认知健康结果联系起来.
- 确定是否需要进一步研究,特别是随机对照试验,以确定因果关系.
主要方法:
- 对观察性研究的综述,研究了遵守地中海饮食与认知功能/AD风险之间的关联.
- 对潜在的生物学机制的分析,这可能是饮食的影响的基础,如血管,代谢和抗炎途径.
- 在地中海饮食中确定特定的饮食成分,这些成分可能会带来认知益处.
主要成果:
- 观察性研究表明,较高的地中海饮食坚持和较低的认知衰退和AD风险之间的相关性.
- 蔬菜,水果,鱼类和健康脂肪等特定成分可能有助于认知健康.
- 目前的证据不足以确定因果关系或推地中海饮食作为AD的最终预防策略.
结论:
- 地中海饮食显示出潜在的减轻认知衰退和AD风险的承诺.
- 进一步的大规模随机对照试验对于证实这些发现和阐明因果关系至关重要.
- 需要更多的研究来确定地中海饮食对阿尔茨海默病预防的特定有益成分和机制.
更多相关视频
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
440
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
19.0K
相关概念视频
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Dementia
99
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
99
Role of Neurotransmitters in Memory
466
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
466
Psychoneuroimmunology: Diabetes and Cancer
25
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
25
